|
||
RII and
Inhibits Human B Cell Antibody Production
By



From the * Immunobiologie Moléculaire, Unité Mixte de Recherche 49, Centre National de la Recherche
Scientifique-Ecole Normale Supérieure Lyon, 69364 Lyon Cedex 07, France; Despite the development of an efficient specific immune response during measles virus (MV)
infection, an immunosuppression occurs contributing to secondary infections. To study the
role of nucleocapsid protein (NP) in MV-induced immunosuppression, we produced recombinant MV NP. Purified recombinant NP exhibited biochemical, antigenic, and tridimensional
structure similar to viral NP. By flow cytometry, we showed that viral or recombinant NP
bound to human and murine B lymphocytes, but not to T lymphocytes. This binding was specific, independent of MHC class II expression, and dependent of the B lymphocyte activation
state. The murine IIA1.6 B cell line, deficient in the Fc receptor for IgG (Fc
U396, Institut des
Cordeliers, 75006 Paris, France; § U404, Institut Pasteur de Lyon, 69365 Lyon Cedex 07, France;
and
U391, 35043 Rennes Cedex, France
RII) expression,
did not bind NP efficiently. Transfected IIA1.6 cells expressing either murine Fc
RIIb1 or b2,
or human Fc
RIIa, b1*, or b2 isoforms efficiently bound NP. Furthermore, this binding was
inhibited up to 90% by monoclonal antibodies 2.4G2 or KB61 specific for murine and human
Fc
RII, respectively. Finally, the in vitro Ig synthesis of CD40- or Ig-activated human B lymphocytes in the presence of interleukin (IL)-2 and IL-10 was reduced by 50% in the presence
of recombinant NP. These data demonstrate that MV NP binds to human and murine Fc
RII
and inhibits in vitro antibody production, and therefore suggests a role for NP in MV-induced immunosuppression.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|